Pharmaceutical Development and Technology最新文献

筛选
英文 中文
Methotrexate multivesicular liposome sustained alleviates rheumatoid arthritis in rats. 甲氨蝶呤多泡脂质体持续缓解大鼠类风湿关节炎。
IF 2.9 4区 医学
Pharmaceutical Development and Technology Pub Date : 2026-11-14 DOI: 10.1080/10837450.2026.2759133
Liying Zhang, Yudan Lu, Dawei Chen, Ming Zhao, Haiyang Hu
{"title":"Methotrexate multivesicular liposome sustained alleviates rheumatoid arthritis in rats.","authors":"Liying Zhang, Yudan Lu, Dawei Chen, Ming Zhao, Haiyang Hu","doi":"10.1080/10837450.2026.2759133","DOIUrl":"10.1080/10837450.2026.2759133","url":null,"abstract":"<p><p>Rheumatoid arthritis (RA) is a chronic inflammatory disease that can cause progressive joint damage. Although methotrexate (MTX) is a first-line treatment for RA, conventional administration may cause systemic adverse effects, highlighting the need for sustained local drug delivery. This study aimed to develop MTX-loaded multivesicular liposomes (MTX-MVLs) for sustained intra-articular delivery and improved RA treatment. MTX-MVLs were prepared using a double-emulsion method and optimized for formulation and process parameters. Their physicochemical properties, <i>in vitro</i> drug release, therapeutic efficacy, joint retention, and systemic safety were evaluated. The optimized MTX-MVLs exhibited high drug encapsulation efficiency and sustained drug release. In an adjuvant-induced arthritis rat model, a single weekly intra-articular injection of MTX-MVLs achieved therapeutic efficacy comparable to biweekly injections of free MTX, while reducing joint swelling and pro-inflammatory cytokine levels. MTX-MVLs also demonstrated prolonged joint retention and a favorable organ safety profile. These findings suggest that MTX-MVLs may provide a promising sustained-release platform for local MTX delivery and warrant further investigation for RA treatment.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"1-15"},"PeriodicalIF":2.9,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149323878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of Monocarboxylate Transporter 4 Inhibitor/Docetaxel-Loaded Multilayer Nanoparticles for Prostate Cancer Combination Therapy. 单羧酸转运蛋白4抑制剂/多西他赛负载多层纳米颗粒用于前列腺癌联合治疗的开发。
IF 2.9 4区 医学
Pharmaceutical Development and Technology Pub Date : 2026-11-13 DOI: 10.1080/10837450.2026.2763654
T'Onj D McGriff, Albert N Ngo, Kamryn Jackson, Ramesh B Badisa, Lacy Myers, Sanjay K D Singh, Wang Zhang, Karam F A Soliman
{"title":"Development of Monocarboxylate Transporter 4 Inhibitor/Docetaxel-Loaded Multilayer Nanoparticles for Prostate Cancer Combination Therapy.","authors":"T'Onj D McGriff, Albert N Ngo, Kamryn Jackson, Ramesh B Badisa, Lacy Myers, Sanjay K D Singh, Wang Zhang, Karam F A Soliman","doi":"10.1080/10837450.2026.2763654","DOIUrl":"https://doi.org/10.1080/10837450.2026.2763654","url":null,"abstract":"<p><p>The proposed work seeks to develop and characterize a smart, multilayer MCT4i/DXT-loaded polylactide-glycolic acid nanoparticle for combination therapy in prostate cancer. The core of the smart LBL NPs is prepared by nanoprecipitation, and the sodium acetate \"freeze-coating\" technique is used to construct the multilayer nanoparticle. The size, zeta potential, entrapment efficiency, and nanoparticle surface chemistry are characterized by Malvern Panalytical Advanced Zeta Sizer. UV/VIS Spectrophotometer, transmission electron microscopy (TEM), and Fourier Transform Infrared spectrometer (FT-IR). The cytotoxicity of the different nanoformulations is assessed in the C4-2 cell line by MTS assay, and the mechanism of cell death is assessed by flow cytometry using an apoptosis assay. The TEM shows a multi-layer spherical nanoparticle. The multilayer nanoparticle is 255.539 nm in size, with an entrapment efficiency of 89.56 ± 1. 70% and 91.55 ± 7.82% for compound AZD0095 and docetaxel, respectively. The FTIR confirms that sodium acetate coats all the nanoformulation. Low-dose combination therapy effectively inhibits C4-2 cell growth. Smart nanoparticles exhibit dose-dependent cytotoxicity in C4-2 cells. Cell death occurs via apoptosis with docetaxel alone and via secondary necrosis with the combination therapy. The multilayer nanoparticle is a promising nanomedicine for combination therapy in prostate cancer.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"1-37"},"PeriodicalIF":2.9,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149409532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quality by design strategies for bioequivalent generic immediate- and sustained-release tablets: a practical development roadmap. 生物等效仿制药即刻缓释片的质量设计策略:一个实用的发展路线图。
IF 2.9 4区 医学
Pharmaceutical Development and Technology Pub Date : 2026-11-13 DOI: 10.1080/10837450.2026.2761009
Sivakumar Thanikachalam
{"title":"Quality by design strategies for bioequivalent generic immediate- and sustained-release tablets: a practical development roadmap.","authors":"Sivakumar Thanikachalam","doi":"10.1080/10837450.2026.2761009","DOIUrl":"10.1080/10837450.2026.2761009","url":null,"abstract":"<p><p>Quality by Design (QbD) provides a science- and risk-based framework for developing generic immediate-release (IR) and sustained-release (SR) tablets. Its practical value, however, depends on translating formulation and process knowledge into evidence supporting bioequivalence (BE), manufacturing robustness, and regulatory decisions. This review presents a practical development roadmap integrating reference listed drug characterization, critical material attributes, critical process parameters, Design of Experiments (DoE), dissolution assessment, BE strategy, design-space justification, and scale-up verification. Its distinctive contribution is an evidence-to-decision framework combining sequential development gates with an evidence hierarchy that distinguishes experimental observations, model-derived inferences, and product-level conclusions. The review compares IR and SR development priorities, including potential Biopharmaceutics Classification System-based biowaivers for eligible IR products and polymer attributes, dissolution kinetics, food effects, and dose-dumping risks for SR formulations. Quantitative case studies illustrate formulation optimization, dissolution modelling, process analytical technology, and commercial-scale assessment, while highlighting the limitations of individual studies in establishing BE or generalized improvements in development efficiency and manufacturing robustness. Artificial intelligence, Bayesian optimization, and continuous manufacturing are critically examined, with emphasis on model validation, independent confirmation, clinically relevant dissolution testing, and representative scale-up evidence. The proposed roadmap supports systematic experimental planning, evidence interpretation, and scientifically justified development and regulatory decisions for generic IR and SR tablets.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"1-22"},"PeriodicalIF":2.9,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149357854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Green development of Cefuroxime-Loaded Chitosan Nanoparticle Microneedles using citric acid crosslinker: A New Approach for targeted Ocular Infection. 柠檬酸交联剂负载头孢呋辛的壳聚糖纳米微针的绿色开发:靶向眼部感染的新途径。
IF 2.9 4区 医学
Pharmaceutical Development and Technology Pub Date : 2026-11-11 DOI: 10.1080/10837450.2026.2759087
Lina Almasri, Ahlam Zaid Alkilani, Lubna Swellmeen
{"title":"Green development of Cefuroxime-Loaded Chitosan Nanoparticle Microneedles using citric acid crosslinker: A New Approach for targeted Ocular Infection.","authors":"Lina Almasri, Ahlam Zaid Alkilani, Lubna Swellmeen","doi":"10.1080/10837450.2026.2759087","DOIUrl":"https://doi.org/10.1080/10837450.2026.2759087","url":null,"abstract":"<p><p>This study aims to develop chitosan nanoparticles containing cefuroxime sodium, a BCS class 3 drug, which was encapsulated into the nanoparticles using a gelation method and then loaded into dissolving microneedles (DMNs) to enable ocular drug delivery. The nanoparticle formula contained chitosan, citric acid, cefuroxime sodium, and Pluronic F127 at a ratio of (1:1:1:0.05) and exhibited a particle size of 509.97 ± 0.47 nm, and entrapment efficiency (EE%) of 44.94%. The DMNs, prepared by the casting method, was fabricated from carboxymethyl cellulose sodium, sucrose, and polyvinylpyrrolidone, exhibited excellent mechanical strength. The nanoparticle-loaded DMNs successfully penetrated the corneal layer, with a cumulative drug delivery of 75.32 µg/cm2, which was significantly higher than that of DMNs loaded with conventional cefuroxime sodium. The nanoparticle formulation and the conventional cefuroxime sodium formulation had the same minimum inhibitory concentration of 0.90 µg/mL against Staphylococcus aureus, indicating that the pharmacological action was conserved. Additionally, compared to the conventional cefuroxime sodium (2.88 ± 0.05 cm), the nanoparticle formulation showed a noticeably broader inhibitory zone (3.48 ± 0.05 cm), suggesting an increase in antibacterial diffusion. In conclusion, the fabricated DMNs demonstrated sufficient mechanical strength to effectively penetrate the cornea and dissolve rapidly, which highlights their potential as a promising strategy for ocular drug delivery.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"1-25"},"PeriodicalIF":2.9,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149394924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Challenging the paradigm of tablet relaxation in continuous coating: analysis of tablet dimensional changes after continuous direct compression. 挑战连续包衣中片剂松弛的范式:连续直接压缩后片剂尺寸变化的分析。
IF 2.9 4区 医学
Pharmaceutical Development and Technology Pub Date : 2026-11-11 DOI: 10.1080/10837450.2026.2761632
Daniel Lutz, Bram Bekaert, Jörg Crönlein, Wouter Grymonpré, Claudia S Leopold
{"title":"Challenging the paradigm of tablet relaxation in continuous coating: analysis of tablet dimensional changes after continuous direct compression.","authors":"Daniel Lutz, Bram Bekaert, Jörg Crönlein, Wouter Grymonpré, Claudia S Leopold","doi":"10.1080/10837450.2026.2761632","DOIUrl":"https://doi.org/10.1080/10837450.2026.2761632","url":null,"abstract":"<p><p>Tablet dimensional changes are one hurdle in continuous coating. The aim of the present study was to evaluate whether a time period of tablet core relaxation is needed prior to coating. The conditions for the experiments were chosen such that maximum tablet core dimensional changes were achieved as challenge for subsequent coating. Three powder blend compositions containing the (super)disintegrants Starch 1500® and/or crospovidone resulting in tablet cores with different relaxation tendency were coated immediately or 24 h after compaction with three immediate release Opadry<sup>®</sup> coatings of variable flexibility to show a potential impact on the coating quality. 'Dry' and 'moist' coating conditions were applied by variation of the coating suspension spray rates. The tablets increased significantly in tablet dimensions depending on their formulation. Despite these dimensional changes, the quality of the coatings was satisfactory as no defects were found. In addition, no differences were observed in the coating thickness of the three coated tablet formulations. The expected defects in the coatings were only found under high humidity storage conditions. In conclusion, the presented results revealed that no relaxation time interval between compaction and coating was necessary, indicating only minor relevance of the elastic relaxation in (continuous) tablet coating following continuous direct compression.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"1-26"},"PeriodicalIF":2.9,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149394923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High-Pressure Homogenisation Enhances The Physicochemical Performance, Stability and Anticancer Activity of Zn(DDC)2-Loaded Liposomes. 高压均质提高Zn(DDC)2负载脂质体的物理化学性能、稳定性和抗癌活性。
IF 2.9 4区 医学
Pharmaceutical Development and Technology Pub Date : 2026-11-11 DOI: 10.1080/10837450.2026.2762195
Irfan Bashir, Ayse Kaya, Sahrish Rehmani, Mouhamad Khoder, Mohammad Najlah
{"title":"High-Pressure Homogenisation Enhances The Physicochemical Performance, Stability and Anticancer Activity of Zn(DDC)<sub>2</sub>-Loaded Liposomes.","authors":"Irfan Bashir, Ayse Kaya, Sahrish Rehmani, Mouhamad Khoder, Mohammad Najlah","doi":"10.1080/10837450.2026.2762195","DOIUrl":"https://doi.org/10.1080/10837450.2026.2762195","url":null,"abstract":"<p><p>Zinc diethyldithiocarbamate (Zn(DDC)<sub>2</sub>) is a lipophilic metal-dithiocarbamate complex with anticancer potential, but poor aqueous solubility limits its pharmaceutical development. This study compared high-pressure homogenisation (HPH) and probe sonication for preparing Zn(DDC)<sub>2</sub>-loaded liposomes and evaluated their effects on formulation performance, stability and cytotoxicity. Liposomes composed of hydrogenated soy phosphatidylcholine, cholesterol and Zn(DDC)<sub>2</sub> were prepared at molar ratios of 45:45:10 and 60:30:10, processed by HPH or probe sonication, and characterised for particle size, PDI, zeta potential, encapsulation efficiency, pH, osmolality, release, 28-day stability and A549 cytotoxicity. HPH produced smaller vesicles (178.0 ± 11.1 and 179.7 ± 15.2 nm), higher-magnitude zeta potentials (-16.4 ± 0.5 and -21.4 ± 1.6 mV), improved encapsulation efficiency and more sustained release than probe sonication. The optimised HPH formulation released 81.4 ± 3.9% Zn(DDC)<sub>2</sub> over 24 h compared with 98.3 ± 1.4% from the corresponding sonicated formulation. HPH liposomes also maintained greater physicochemical stability over 28 days. In A549 cells, HPH liposomes showed significantly greater cytotoxicity (IC<sub>50</sub> = 3.82 ± 0.75 µM) than sonicated liposomes (7.68 ± 2.51 µM) and free Zn(DDC)<sub>2</sub> (54.63 ± 1.59 µM) (p < 0.05). These findings support HPH as a scalable platform for Zn(DDC)<sub>2</sub> liposomal delivery and underline the importance of manufacturing process selection in optimising liposomal anticancer formulations.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"1-16"},"PeriodicalIF":2.9,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149394925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alginate-Bean Starch Expandable Films Incorporating Capsicum Extract: An Innovative Delivery System for Obesity Management. 含有辣椒提取物的海藻酸豆淀粉膨胀膜:肥胖管理的创新输送系统。
IF 2.9 4区 医学
Pharmaceutical Development and Technology Pub Date : 2026-11-11 DOI: 10.1080/10837450.2026.2760435
Md Abu Jar Gifari, Rachanida Praparatana, Yaowaporn Sangsen, Kantiya Fungfoung, Worrawee Siripruekpong, Ruedeekorn Wiwattanapatapee
{"title":"Alginate-Bean Starch Expandable Films Incorporating Capsicum Extract: An Innovative Delivery System for Obesity Management.","authors":"Md Abu Jar Gifari, Rachanida Praparatana, Yaowaporn Sangsen, Kantiya Fungfoung, Worrawee Siripruekpong, Ruedeekorn Wiwattanapatapee","doi":"10.1080/10837450.2026.2760435","DOIUrl":"https://doi.org/10.1080/10837450.2026.2760435","url":null,"abstract":"<p><p>Gastroretentive expandable films were developed for the control release of capsicum extract for obesity management. Capsicum extract (0.3% w/v, equivalent to 0.03% capsaicin) was incorporated into films composed of different types of bean starch (mung bean, white bean, and red bean starch), sodium alginate, and HPMC K100 using a solvent casting technique, with glycerin as a plasticizer. The optimized formulation (G4), based on mung bean starch, exhibited desirable unfolding and swelling properties and achieved 82.8% capsaicin release over 8 hours in simulated gastric fluid. It also demonstrated a tensile strength of 17.55 ± 0.72 kg/cm<sup>2</sup> and an expansion factor of 1.25 ± 0.01. Furthermore, the capsaicin-loaded films showed dose-dependent anti-obesity activity in 3T3-L1 cells. These findings highlight the potential of bean starch-based expandable films as a nutritionally favorable and effective gastroretentive delivery system for capsicum extract in obesity therapy.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"1-20"},"PeriodicalIF":2.9,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149394922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A dissolution-enhancing strategy for clopidogrel napadisilate: surfactant-assisted wet granulation and particle size engineering. 纳帕二酸氯吡格雷的溶解增强策略:表面活性剂辅助湿造粒和粒径工程。
IF 2.9 4区 医学
Pharmaceutical Development and Technology Pub Date : 2026-11-05 DOI: 10.1080/10837450.2026.2759088
Kwang Young Lee, Taek Kwan Kwon, Ho Taek Im, Kyung-Tae Lee, Jung Hyun Cho
{"title":"A dissolution-enhancing strategy for clopidogrel napadisilate: surfactant-assisted wet granulation and particle size engineering.","authors":"Kwang Young Lee, Taek Kwan Kwon, Ho Taek Im, Kyung-Tae Lee, Jung Hyun Cho","doi":"10.1080/10837450.2026.2759088","DOIUrl":"10.1080/10837450.2026.2759088","url":null,"abstract":"<p><p>Clopidogrel napadisilate hydrate is a stable clopidogrel salt, but its low aqueous solubility limits dissolution. This study developed a spray-drying-free tablet using surfactant-assisted wet granulation and jet milling. Among four surfactants screened at pH 2.0, polysorbate 80 (PS80) yielded the highest similarity factor (f<sub>2</sub> = 74.6 vs. 19.5-59.8; <i>n</i> = 3 tablets). Response surface methodology identified PS80 concentration as the main determinant of f<sub>2</sub>. At pH 4.5, API particle size was dominant: reducing D90 from 208.2 to 16.2 μm increased f<sub>2</sub> from 31.9 to 82.8 with acceptable flowability, whereas 6.6 μm impaired flowability without further benefit. The model-predicted optima (0.84 mg PS80; D90 11.9 μm) were not prepared as batches; the selected conditions (1.0 mg PS80; D90 16.2 μm) yielded f<sub>2</sub> values exceeding the predictions (74.6 vs. 70.3; 82.8 vs. 80.0). PXRD and DSC detected no crystalline transformation, although hydrate water content was not determined. In an exploratory parallel-group beagle dog study (<i>n</i> = 6 per group), C<sub>max</sub> and AUC<sub>0</sub>-<sub>24</sub> of parent clopidogrel did not differ significantly from Plavix<sup>®</sup> (<i>p</i> = 0.774 and 0.910); bioequivalence and active-metabolite exposure were not assessed. These results identify API particle size as critical for pH 4.5 dissolution and support conventional wet granulation with jet milling as a practical alternative to amorphous or spray-dried approaches.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"1-18"},"PeriodicalIF":2.9,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149323877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Potential use of cellulose nanocrystals as multifunctional excipient in chlorphenamine maleate nasal spray formulations. 纤维素纳米晶体在马来酸氯苯那敏鼻喷雾剂中作为多功能赋形剂的潜在用途。
IF 2.9 4区 医学
Pharmaceutical Development and Technology Pub Date : 2026-11-04 DOI: 10.1080/10837450.2026.2755853
Marcos Mariano, Emma Kearney, Elray Ng, Lorna O'Dwyer, Helen Cathcart
{"title":"Potential use of cellulose nanocrystals as multifunctional excipient in chlorphenamine maleate nasal spray formulations.","authors":"Marcos Mariano, Emma Kearney, Elray Ng, Lorna O'Dwyer, Helen Cathcart","doi":"10.1080/10837450.2026.2755853","DOIUrl":"https://doi.org/10.1080/10837450.2026.2755853","url":null,"abstract":"<p><p>Nasal spray performance depends strongly on excipient properties, which govern plume formation, droplet size, and mucociliary retention. However, currently available excipients rarely combine these functionalities. In alignment with the FDA's PRIME initiative for excipient modernisation, we demonstrate that cellulose nanocrystals (CNCs) represent a promising class of multifunctional excipients. As a case study, we evaluated CNCs as multifunctional excipients in chlorphenamine maleate (CM) formulations. Samples containing up to 2 wt% CNC delivered uniform doses, tunable plume areas (30-61 cm<sup>2</sup>), and stable droplet sizes (d50 = 116-189 µm). Owing to their anisotropic shape, the nanoparticles exhibited shear-thinning behaviour with partial viscosity recovery after shear. However, the presence of CM significantly amplified thixotropy and increased suspension viscosity up to 200-fold at higher CNC concentrations (i.e. 4 wt%). Calorimetric measurements revealed the spontaneous character of the CM-CNC interactions (ΔG = -26.7 kJ/mol), with exothermic enthalpy (ΔH = -15.5 kJ/mol) and a positive entropic term (ΔS = 37.38 J/(mol·K)), suggesting a significant hydrophobic contribution to binding affinity. Such interactions increased CM solubility three-fold (25-80 mg mL<sup>-1</sup>), enabling substantially higher drug loading. At CNC concentrations above 2 wt%, gelation occurred and prevented spray formation. Overall, these results demonstrate that CNCs can function as multifunctional excipients for nasal spray formulations by simultaneously tuning spray performance and enhancing drug solubility.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"1-10"},"PeriodicalIF":2.9,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149334908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhanced bioavailability and gastric protection of the NSAIDs meloxicam-cyclodextrin microparticles. 非甾体抗炎药美洛昔康-环糊精微粒增强生物利用度和胃保护作用。
IF 2.9 4区 医学
Pharmaceutical Development and Technology Pub Date : 2026-11-03 DOI: 10.1080/10837450.2026.2757869
Adel Al Fatease, Hamdy Abdelkader, Zeinab Fathalla, Heba Salah Mousa, Jelan A Abdel-Aleem, Heba A Abou-Taleb
{"title":"Enhanced bioavailability and gastric protection of the NSAIDs meloxicam-cyclodextrin microparticles.","authors":"Adel Al Fatease, Hamdy Abdelkader, Zeinab Fathalla, Heba Salah Mousa, Jelan A Abdel-Aleem, Heba A Abou-Taleb","doi":"10.1080/10837450.2026.2757869","DOIUrl":"10.1080/10837450.2026.2757869","url":null,"abstract":"<p><p>Non-steroidal anti-inflammatory drugs (NSAIDs) are widely prescribed for painful and inflammatory disorders; however, poor bioavailability and gastric ulceration may limit therapeutic outcomes. This study, the first to integrate four cyclodextrins (CDs), gastric safety, bioavailability, and green HPLC validation, aimed to prepare meloxicam (Melo)-CD supramolecular complexes to enhance solubility, dissolution, bioavailability, and reduce ulcerogenic potential following 10-day repeated administration. Native β-CD and three derivatives were complexed with Melo using physical mixing (PM) and coprecipitation (Coppt). The optimized Melo (HP)-β-CD Coppt was compressed into tablets and compared with commercial immediate-release tablets. Complexes were characterized by particle size analysis, solubility, molecular docking, dissolution, differential scanning calorimetry, and Fourier-transform infrared spectroscopy, followed by <i>in vivo</i> gastric safety evaluation in rodents. A rapid, sensitive, eco-friendly, and cost-effective greenness-assisted HPLC method was developed and validated for Melo determination in plasma. Docking suggested inclusion complexation with HP- and hydroxyethyl (HE)-β-CDs. Solubility and dissolution increased by up to 575- and 25-fold, respectively. HEβ-CD complexes provided superior gastric protection without submucosal scarring or fibrosis. HP β-CD complexes significantly enhanced oral Melo bioavailability by over fivefold versus commercial tablets (<i>p</i> < 0.01). These findings highlight CDs as promising solubilizing and safety-enhancing excipients for Melo and potentially other NSAIDs.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"1-18"},"PeriodicalIF":2.9,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149299787","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书